Last Price
0.121
Today's Change
+0.009 (8.029%)
Day's Change
0.112 - 0.126
Trading Volume
7,353,562
Market Cap
1 Million
Shares Outstanding
14 Million
Avg Volume
14,923,688
Avg Price (50 Days)
0.27
Avg Price (200 Days)
37.35
PE Ratio
0.00
EPS
628.80
Earnings Announcement
14-Apr-2025
Previous Close
0.11
Open
0.11
Day's Range
0.1115 - 0.126
Year Range
0.107 - 218.0
Trading Volume
7,777,377
1 Day Change
7.43%
5 Day Change
-16.49%
1 Month Change
-34.92%
3 Month Change
-84.91%
6 Month Change
-99.79%
Ytd Change
-38.46%
1 Year Change
-99.93%
3 Year Change
-100.00%
5 Year Change
-100.00%
10 Year Change
-100.00%
Max Change
-100.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.